News
-
First Half 2026 Letter to Shareholders
July 29, 2026 -
Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan's Growing Role in Real-World Clinical Practice
July 21, 2026 -
Aclarion Announces Texas Spine Care Center as New CLARITY Site
July 7, 2026 -
Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub
June 10, 2026 -
Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform
June 9, 2026 -
Aclarion Rejects Echo Lake Capital's Unsolicited Acquisition Proposal
June 8, 2026 -
Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting
June 8, 2026 -
Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation
June 3, 2026 -
Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study
June 1, 2026 -
Aclarion, Inc. Comments on Echo Lake Capital's Letter and Unsolicited Proposal
May 28, 2026